These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 18638294)

  • 1. Pharmacokinetics and physiological effects of intravenous hydromorphone in conscious dogs.
    Guedes AG; Papich MG; Rude EP; Rider MA
    J Vet Pharmacol Ther; 2008 Aug; 31(4):334-43. PubMed ID: 18638294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of plasma histamine levels after intravenous administration of hydromorphone and morphine in dogs.
    Guedes AG; Papich MG; Rude EP; Rider MA
    J Vet Pharmacol Ther; 2007 Dec; 30(6):516-22. PubMed ID: 17991219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and physiological effects of two intravenous infusion rates of morphine in conscious dogs.
    Guedes AG; Papich MG; Rude EP; Rider MA
    J Vet Pharmacol Ther; 2007 Jun; 30(3):224-33. PubMed ID: 17472654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental pharmacodynamics and analgesic efficacy of liposome-encapsulated hydromorphone in dogs.
    Krugner-Higby L; Smith L; Schmidt B; Wunsch L; Smetana A; Brown C; Heath TD
    J Am Anim Hosp Assoc; 2011; 47(3):185-95. PubMed ID: 21498589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations.
    Dohoo SE; Tasker RA
    Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of an immediate and extended release oral morphine formulation utilizing the spheroidal oral drug absorption system in dogs.
    Aragon CL; Read MR; Gaynor JS; Barnhart MD; Wilson D; Papich MG
    J Vet Pharmacol Ther; 2009 Apr; 32(2):129-36. PubMed ID: 19290942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system.
    Ward ME; Woodhouse A; Mather LE; Farr SJ; Okikawa JK; Lloyd P; Schuster JA; Rubsamen RM
    Clin Pharmacol Ther; 1997 Dec; 62(6):596-609. PubMed ID: 9433388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-independent pharmacokinetics of the cardioprotective agent dexrazoxane in dogs.
    Baldwin JR; Lewis RC; Phillips BA; Overmyer SK; Hatfield NZ; Narang PK
    Biopharm Drug Dispos; 1996 Aug; 17(6):541-50. PubMed ID: 8866044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic evaluation of intravenous hydromorphone in cats.
    Wegner K; Robertson SA; Kollias-Baker C; Sams RA; Muir WW
    J Vet Pharmacol Ther; 2004 Oct; 27(5):329-36. PubMed ID: 15500571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic and hyperthermic effects of intravenously administered morphine in the rat are related to its serum levels.
    Bhargava HN; Villar VM; Gulati A; Chari G
    J Pharmacol Exp Ther; 1991 Aug; 258(2):511-6. PubMed ID: 1865354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine and hydromorphone for postoperative analgesia: focus on safety.
    Golembiewski JA
    J Perianesth Nurs; 2003 Apr; 18(2):120-2. PubMed ID: 12710006
    [No Abstract]   [Full Text] [Related]  

  • 12. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ketoconazole on the pharmacokinetics and pharmacodynamics of morphine in healthy Greyhounds.
    Kukanich B; Borum SL
    Am J Vet Res; 2008 May; 69(5):664-9. PubMed ID: 18447799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics and extra-hepatic clearance of remifentanil, a short acting opioid agonist, in male beagle dogs during constant rate infusions.
    Chism JP; Rickert DE
    Drug Metab Dispos; 1996 Jan; 24(1):34-40. PubMed ID: 8825188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of buprenorphine following intravenous administration in dogs.
    Krotscheck U; Boothe DM; Little AA
    Am J Vet Res; 2008 Jun; 69(6):722-7. PubMed ID: 18518651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acepromazine, hydromorphone, or an acepromazine-hydromorphone combination on the degree of sedation in clinically normal dogs.
    Hofmeister EH; Chandler MJ; Read MR
    J Am Vet Med Assoc; 2010 Nov; 237(10):1155-9. PubMed ID: 21073386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of butorphanol in broiler chickens.
    Singh PM; Johnson C; Gartrell B; Mitchinson S; Chambers P
    Vet Rec; 2011 Jun; 168(22):588. PubMed ID: 21628341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of buprenorphine after intravenous administration of clinical doses to dogs.
    Andaluz A; Moll X; Abellán R; Ventura R; Carbó M; Fresno L; García F
    Vet J; 2009 Sep; 181(3):299-304. PubMed ID: 18467137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic modeling of hydromorphone in cardiac surgery patients during postoperative pain therapy.
    Jeleazcov C; Saari TI; Ihmsen H; Mell J; Fröhlich K; Krajinovic L; Fechner J; Schüttler J
    Anesthesiology; 2014 Feb; 120(2):378-91. PubMed ID: 23958818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology and pharmacokinetics of once-daily hydromorphone hydrochloride extended-release capsules.
    Vashi V; Harris S; El-Tahtawy A; Wu D; Cipriano A
    J Clin Pharmacol; 2005 May; 45(5):547-54. PubMed ID: 15831778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.